Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04532424 · ClinicalTrials.gov registry record · NA

Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

A NA study of Autism Spectrum Disorder and Autism, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
67
Enrollment target
1
Study location

NCT04532424 is a NA study of Autism Spectrum Disorder and Autism that is actively recruiting participants, run by Stanford University. The registered enrollment target is 67 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04532424, a NA study of Autism Spectrum Disorder and Autism, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
67 participants
Enrollment target
1
Study location

Study Summary

Investigating the efficacy of a form of TMS called theta-burst stimulation for restricted and repetitive behavior in ASD.

Interventions

  • DEVICE Transcranial magnetic stimulation

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2021-01-04
Est. Completion 2029-12-01
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT04532424

The ClinicalTrials.gov registry entry for NCT04532424 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (50% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Transcranial magnetic stimulation is the first listed.

NCT04532424 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04532424 about?

NCT04532424 is a clinical study titled "Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD". Investigating the efficacy of a form of TMS called theta-burst stimulation for restricted and repetitive behavior in ASD.

What is the current status of trial NCT04532424?

This trial is currently recruiting. It is a NA study. The enrollment target is 67 participants. The study started on 2021-01-04. Estimated completion is 2029-12-01.

What conditions does trial NCT04532424 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism, Asperger Syndrome.

What interventions are being tested in trial NCT04532424?

The interventions under investigation include: Transcranial magnetic stimulation (DEVICE).

Who is sponsoring clinical trial NCT04532424?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04532424 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.